| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6165861 | Urology | 2016 | 5 Pages |
Abstract
In AA men with PSA of 2-10âng/mL, PHI was predictive of pT3 prostate cancer and may help to identify men at increased risk of adverse pathology. Additional studies are needed to substantiate these findings and identify appropriate thresholds for clinical use.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Zeyad R. Schwen, Jeffrey J. Tosoian, Lori J. Sokoll, Leslie Mangold, Elizabeth Humphreys, Edward M. Schaeffer, Alan W. Partin, Ashley E. Ross,